SCHEMBL12428249

SCHEMBL12428249

Cc1ccc(N2CCCc3cc(-c4ccc(/C=C5\C(=O)N(c6ccccc6)N=C5C(=O)O)s4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 4/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ALDH1A1 P00352 6/20 0.38
MAPT P10636 6/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
L3MBTL1 Q9Y468 4/20 0.38
HPGD P15428 4/20 0.38
LMNA P02545 3/20 0.38
KDM4E B2RXH2 3/20 0.38
TDP1 Q9NUW8 3/20 0.38
HTT P42858 2/20 0.38
MAPK1 P28482 1/20 0.38
SCN9A Q15858 2/20 0.37
KAT8 Q9H7Z6 3/20 0.36
CREBBP Q92793 1/20 0.35
GAA P10253 1/20 0.35
PRF1 P14222 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428261 0.98 EP300 (0.40) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428264 0.98 EP300 (0.40) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428451 0.93 SCN9A (0.38) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428273 0.90 SCN9A (0.36) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428430 0.90 SCN9A (0.42) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428262 0.87 MEN1 (0.38) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428432 0.85 KAT8 (0.45) EP300HDAC6ALDH1A1MAPTMEN1
SCHEMBL12428121 0.85 KAT8 (0.45) EP300ALDH1A1MAPTMEN1KMT2A
SCHEMBL12428202 0.84 KAT8 (0.43) ALDH1A1MAPTMEN1KMT2AL3MBTL1
SCHEMBL12428259 0.84 SCN9A (0.39) ALDH1A1MAPTMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 EP300 2442/4885HDAC6 4236/4885ALDH1A1 235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.